Lewy body dementia (LBD) is a challenging-to-diagnose neurodegenerative disease with symptoms similar to both Parkinson’s and Alzheimer’s diseases, including hallucinations, cognitive issues, and movement disorders. To study LBD’s progression, researchers developed mini brain models from LBD patient stem cells, replicating key disease characteristics seen in human brains. These models helped identify four promising drugs that may inhibit alpha-synuclein buildup, a key protein associated with LBD.
You May Also Like
Listening to Music After Surgery Lowers Pain and Anxiety
October 19, 2024
How a Brain Lipid’s Production Could Impact Dementia
October 18, 2024
Disrupted Protein Clearance After TBI Tied to Alzheimer’s
October 18, 2024
More From Author
Why PTSD Develops in Some but Not Others
October 21, 2024
New Genes Linked to Muscle Aging Discovered
October 19, 2024
Listening to Music After Surgery Lowers Pain and Anxiety
October 19, 2024
+ There are no comments
Add yours